Possible role of selective, irreversible, proteasome inhibitor (carfilzomib) in the treatment of rat hepatocellular carcinomaMahmoud Mansour, Mahmoud N. Nagi, Mohammed A. Aljoufi et al.|Chemico-Biological Interactions|2014Cited by 13
Therapeutic potential of carfilzomib, an irreversible proteasome inhibitor, against acetaminophen-induced hepatotoxicity in miceAbdulrazaq Alanazi, Mahmoud N. Nagi, Saleh G. Algfeley et al.|Journal of Biochemical and Molecular Toxicology|2016Cited by 7
A Possible Antineoplastic Potential of Selective, Irreversible Proteasome Inhibitor, Carfilzomib on Chemically Induced Hepatocarcinogenesis in RatsMahmoud Mansour, Mahmoud N. Nagi, Mohammed A. Aljoufi et al.|Journal of Biochemical and Molecular Toxicology|2014Cited by 5